1. Home
  2. ELSE vs HIND Comparison

ELSE vs HIND Comparison

Compare ELSE & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

HOLD

Current Price

$7.63

Market Cap

15.4M

Sector

Industrials

ML Signal

HOLD

HIND

Vyome Holdings Inc.

HOLD

Current Price

$2.07

Market Cap

13.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
HIND
Founded
1968
2017
Country
United States
United States
Employees
N/A
18
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
13.8M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
ELSE
HIND
Price
$7.63
$2.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
31.8K
16.8K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$10,142,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$84.67
N/A
Revenue Growth
8.20
N/A
52 Week Low
$3.65
$1.75
52 Week High
$7.66
$12.87

Technical Indicators

Market Signals
Indicator
ELSE
HIND
Relative Strength Index (RSI) 88.62 40.28
Support Level $4.56 $2.02
Resistance Level N/A $2.43
Average True Range (ATR) 0.04 0.13
MACD 0.11 -0.00
Stochastic Oscillator 99.09 31.11

Price Performance

Historical Comparison
ELSE
HIND

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: